Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
Clinical trial NCT03356223 · COMPLETED
Trial details
- NCT number
- NCT03356223
- Sponsor
- Centre Leon Berard
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2022-11-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.